IL21639A - Preparation of cephalosporin c derivatives - Google Patents

Preparation of cephalosporin c derivatives

Info

Publication number
IL21639A
IL21639A IL21639A IL2163964A IL21639A IL 21639 A IL21639 A IL 21639A IL 21639 A IL21639 A IL 21639A IL 2163964 A IL2163964 A IL 2163964A IL 21639 A IL21639 A IL 21639A
Authority
IL
Israel
Prior art keywords
cephalosporin
derivatives
preparation
Prior art date
Application number
IL21639A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IL21639A publication Critical patent/IL21639A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL21639A 1963-07-15 1964-07-02 Preparation of cephalosporin c derivatives IL21639A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB27990/63A GB1101424A (en) 1963-07-15 1963-07-15 Derivatives of 7-aminocephalosporanic acid
GB27989/63A GB1101423A (en) 1963-07-15 1963-07-15 Derivatives of 7-aminocephalosporanic acid
GB1474764 1964-04-09
GB1474864 1964-04-09

Publications (1)

Publication Number Publication Date
IL21639A true IL21639A (en) 1968-04-25

Family

ID=27448261

Family Applications (2)

Application Number Title Priority Date Filing Date
IL6421640A IL21640A (en) 1963-07-15 1964-07-02 Cephalosporin c derivatives
IL21639A IL21639A (en) 1963-07-15 1964-07-02 Preparation of cephalosporin c derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL6421640A IL21640A (en) 1963-07-15 1964-07-02 Cephalosporin c derivatives

Country Status (13)

Country Link
US (2) US3261832A (xx)
BE (2) BE650444A (xx)
BR (1) BR6460800D0 (xx)
CH (2) CH469022A (xx)
CS (1) CS166185B2 (xx)
DE (1) DE1445835B2 (xx)
DK (2) DK120544C (xx)
FR (2) FR1455030A (xx)
GB (2) GB1101424A (xx)
IL (2) IL21640A (xx)
NL (3) NL6408066A (xx)
NO (1) NO128157B (xx)
SE (1) SE335532B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365449A (en) * 1964-07-23 1968-01-23 Fujisawa Pharmaceutical Co 7-(substituted thioacylamino) cephalosporanic acid and derivatives thereof
US3360515A (en) * 1964-07-24 1967-12-26 Fujisawa Pharmaceutical Co 7-(condensed n-containing heterocyclic carbonamido) cephalosporanic acid and derivatives thereof
US3479350A (en) * 1966-12-05 1969-11-18 Glaxo Lab Ltd Process for the manufacture of derivatives of cephalosporin c
GB1277415A (en) * 1968-06-14 1972-06-14 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
US3687948A (en) * 1970-11-23 1972-08-29 Bristol Myers Co 7-{8 D-(a-AMINO-a-PHENYLACETAMIDO){9 -3-(4-METHYL-1,3-OXAZOL-2-YLTHIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACID AND SALTS THEREOF
US4024135A (en) * 1976-03-05 1977-05-17 E. R. Squibb & Sons, Inc. (Carbamoyl)pyridino derivatives of ureidocephalosporins
GB1565941A (en) * 1977-02-08 1980-04-23 Toyama Chemical Co Ltd Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids
JPS6027677B2 (ja) * 1978-07-06 1985-06-29 富山化学工業株式会社 ７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates
EP0070706B1 (en) * 1981-07-17 1987-12-23 Glaxo Group Limited Cephalosporin compounds
CA2935651A1 (en) 2007-10-09 2009-04-16 Gladius Pharmaceuticals Corporation Broad spectrum beta-lactamase inhibitors
US20120329770A1 (en) * 2010-02-26 2012-12-27 Gary Igor Dmitrienko Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof

Also Published As

Publication number Publication date
FR4315M (xx) 1966-08-01
DK120544B (xx) 1971-06-14
DE1445835B2 (de) 1976-04-22
NO128157B (xx) 1973-10-08
BE650444A (xx) 1965-01-11
CH469739A (de) 1969-03-15
FR1455030A (fr) 1966-04-01
DE1445835A1 (de) 1969-01-09
GB1101424A (en) 1968-01-31
IL21640A (en) 1968-04-25
DK124334B (da) 1972-10-09
CH469022A (de) 1969-02-28
NL6408066A (xx) 1965-01-18
SE335532B (xx) 1971-06-01
US3243435A (en) 1966-03-29
GB1101423A (en) 1968-01-31
DK120544C (da) 1971-11-08
BE650445A (xx) 1965-01-11
BR6460800D0 (pt) 1973-08-02
US3261832A (en) 1966-07-19
NL6408067A (xx) 1965-01-18
NL130098C (xx)
CS166185B2 (xx) 1976-01-29

Similar Documents

Publication Publication Date Title
IL21639A (en) Preparation of cephalosporin c derivatives
IL21692A (en) Derivatives of alpha-alkylidene-sulfonylphenoxyacetic acid
IL33395A (en) Preparation of 17alpha-methyl-des-a-pregnane derivatives
IL32873A (en) Derivatives of pregnane
CA641604A (en) Derivatives of cephalosporin c
AU288621B2 (en) Derivatives of cephalosporin c
IL22593A (en) Preparation of diakylphenols
AU4639564A (en) Derivatives of cephalosporin c
MY7300505A (en) Derivatives of &-aminopenicillins
CA667280A (en) Derivatives of 4-phenylpiperidine-4-carboxylate
CA667862A (en) Derivatives of 2-mercaptopyridine-1-oxide
CA661959A (en) Derivatives of thiaxanthenone
AU294549B2 (en) Derivatives of fluorochlorobenzenes
CA667859A (en) Derivatives of 2-mercaptopyridine-1-oxide
CA667860A (en) Derivatives of 2-mercaptopyridine-1-oxide
CA667861A (en) Derivatives of 2-mercaptopyridine-1-oxide
AU276757B2 (en) Derivatives of 6-chromanols
CA667863A (en) Derivatives of 2-mercaptopyridine-1-oxide
CA667870A (en) Derivatives of 2-mercaptopyridine-1-oxide
CA673345A (en) Derivatives of thiaxanthenone
AU280811B2 (en) Derivatives of fluorochlorobenzenes
IE26820L (en) Derivatives of cephalosporin
AU288661B2 (en) Process forthe preparation of cephalosporin derivatives
AU4854164A (en) Derivatives of fluorochlorobenzenes
AU4898564A (en) Derivatives of fluorochlorobenzenes